Bilirubin Blood Test Market 2018 | Pivotal Players as Koninklijke Philips N.V., Randox Laboratories Limited, etc

MarketResearchFuture.com (MRFR) in it’s recently Announced study report asserts that the “Global Bilirubin Blood Test Market”. Registering 5.44% CAGR Along with Top Companies, Mega Trends & market synopsis up to 2027.

Bilirubin Blood Test Market - Scenario:

Bilirubin is a yellowish pigment which is primarily formed by the normal breakdown of heme. Heme is a component of hemoglobin found in red blood cells. The liver eventually processes bilirubin to allow its elimination from the body. The test measures the amount of bilirubin in the blood to assess a person's liver function or to help diagnose anemias caused by RBC destruction (hemolytic anemia).

The global bilirubin blood test market is expected to show a notable 5.44% CAGR during the forecast period of 2017 to 2027. An increasing demand for portable/hand-held diagnostic devices and an increasing high prevalence of neonatal jaundice in infants are the major factors for influencing the bilirubin blood test market.

Request for Sample Report at https://www.marketresearchfuture.com/sample_request/720

According to statistics published by the National Center for Biotechnology Information, nearly 60% to 80% of healthy newborns are prone to develop hyperbilirubinemia. The aspect hindering the growth of the bilirubin blood test market is the testing performed by non-laboratory personnel.

Bilirubin Blood Test Market - Regional Analysis:

The bilirubin blood test market is segmented into the Americas, Europe, Asia-Pacific and Middle East & Africa.

North America holds the largest market share in the global bilirubin blood test market. Increasing prevalence of neonatal jaundice among infants and high disposable income coupled with well-structured healthcare sector in the region fuels the market growth.

Europe is anticipated to be the second leading market for bilirubin blood test market owing to rising expenditure healthcare services whereas Asia-Pacific is expected to be the third and fastest growing market for the bilirubin blood test market due to growing economy and favorable government policies of developing economies like India and China which foster the market growth.

Furthermore, the Middle East and Africa region holds the least market share. The market in this region is expected to grow at a slower pace due to improving healthcare infrastructure.

Global Bilirubin Blood Test Market – Competitive Landscape

The global bilirubin blood test market is observed to be growing upwards due to technological advancements of key players like Koninklijke Philips N.V., Randox Laboratories Limited, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc. and Beckman Coulter, Inc. The well-established market players are involved in strategic collaborations, partnerships, and product updates to gain competitive advantage in this market.

Ask Any Question at https://www.marketresearchfuture.com/enquiry/720

In June 2018, Koninklijke Philips N.V., operating as a health technology company acquired Remote Diagnostic Technologies Limited, which designs and manufactures remote monitoring and solutions.

In January 2018, F. Hoffmann-La Roche AG announced that it had entered into a strategic, long-term partnership with GE Healthcare in order to jointly develop and co-market digital clinical decision support solutions. The companies aim to develop jointly-branded clinical decision support software for faster, more accurate, more confident decision-making, enabling earlier diagnosis and individualized treatment.

In June 2017, Grifols, a leader in the development of innovative diagnostic solutions, and Beckman Coulter Inc., a leading provider of innovative, efficient and reliable diagnostics solutions, have entered into an exclusive, long-term distribution agreement. This collaboration leverages Grifols' strength in manufacturing reliable instruments and reagents with that of Beckman Coulter's commercial strength.

In July 2016, Thermo Fisher Scientific Inc., the world leader in serving science, and HEALTH BioMed (HBM) announced a collaboration to support HBM’s development of molecular diagnostic (MDx) kits to serve the China market.

In December 2015, Randox Laboratories Ltd. Announced the approval of T BIL (total bilirubin) from Food and Drug Administration. This liquid bilirubin control provided a true third-party solution for the measurement of Bilirubin delivering an unbiased, independent assessment of analytical performance. Two levels: Bilirubin (Direct) Bilirubin (Total) covered the required clinically relevant decision levels for paediatric testing.

Check Discount at https://www.marketresearchfuture.com/check-discount/720

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.